Literature DB >> 22211332

An atypical melanocytic lesion without genomic abnormalities shows locoregional metastasis.

Ronnie M Abraham1, Michael E Ming, David E Elder, Xiaowei Xu.   

Abstract

A subset of difficult melanocytic lesions exists with histopathologic features that evade diagnostic consensus from even expert dermatopathologists. Comparative genomic hybridization (CGH) has emerged as a useful diagnostic tool to categorize these lesions, by identifying known chromosomal aberrations in malignant melanoma or the lack thereof in melanocytic nevi. However, determining a lesion's biological behavior primarily on CGH is limited by a relatively small series of corroborative cases without long term follow up. We present a case of a pigmented lesion on the right cheek of a 4 year old boy. The lesion had features of a deep penetrating nevus, but the presence of frequent mitoses, tumor infiltrating lymphocytes, and microscopic foci of tumor necrosis were concerning for an unusual melanoma. We termed this lesion a melanocytic tumor of uncertain potential (MELTUMP) for these reasons. High-resolution array-CGH performed elsewhere on the lesion demonstrated no melanoma-associated genomic abnormalities. A sentinel lymph node biopsy of this patient later revealed multiple small tumor deposits. Although the presence of nodal involvement in similar lesions often do not lead to progressive and fatal disease, this case illustrates that atypical melanocytic lesions with nodal involvement may not demonstrate genomic abnormalities by CGH, and that histopathologic assessment remains paramount in defining these difficult melanocytic lesions. Further comprehensive study of these lesions is needed.
Copyright © 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22211332      PMCID: PMC3958928          DOI: 10.1111/j.1600-0560.2011.01849.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  19 in total

Review 1.  The approach to the patient with a difficult melanocytic lesion.

Authors:  David E Elder; Xiaowei Xu
Journal:  Pathology       Date:  2004-10       Impact factor: 5.306

2.  Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors.

Authors:  Christina M Lohmann; Daniel G Coit; Mary S Brady; Marianne Berwick; Klaus J Busam
Journal:  Am J Surg Pathol       Date:  2002-01       Impact factor: 6.394

3.  Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms.

Authors:  Bahair Ghazi; Grant W Carlson; Douglas R Murray; Kenneth W Gow; Andrew Page; Megan Durham; David A Kooby; Douglas Parker; Louis Rapkin; David H Lawson; Keith A Delman
Journal:  Ann Surg Oncol       Date:  2010-03-12       Impact factor: 5.344

4.  Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults--the Stanford experience 1995-2008.

Authors:  David R Berk; Elizabeth LaBuz; Soheil S Dadras; Denise L Johnson; Susan M Swetter
Journal:  Pediatr Dermatol       Date:  2010-04-09       Impact factor: 1.588

5.  Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma.

Authors:  David A Biddle; Harry L Evans; Bonnie L Kemp; Adel K El-Naggar; Jeff D Harvell; Wain L White; Sammy S Iskandar; Victor G Prieto
Journal:  Am J Surg Pathol       Date:  2003-05       Impact factor: 6.394

6.  Minimal deviation melanoma: a histologic variant of cutaneous malignant melanoma in its vertical growth phase.

Authors:  J E Muhlbauer; R J Margolis; M C Mihm; R J Reed
Journal:  J Invest Dermatol       Date:  1983-06       Impact factor: 8.551

7.  Classifying melanocytic tumors based on DNA copy number changes.

Authors:  Boris C Bastian; Adam B Olshen; Philip E LeBoit; Daniel Pinkel
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

8.  Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients.

Authors:  Lyndon D Su; Douglas R Fullen; Vernon K Sondak; Timothy M Johnson; Lori Lowe
Journal:  Cancer       Date:  2003-01-15       Impact factor: 6.860

9.  Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.

Authors:  Christina M Lohmann; Kirsten Iversen; Achim A Jungbluth; Marianne Berwick; Klaus J Busam
Journal:  Am J Surg Pathol       Date:  2002-10       Impact factor: 6.394

Review 10.  A practical approach to selected problematic melanocytic lesions.

Authors:  Xiaowei Xu; David E Elder
Journal:  Am J Clin Pathol       Date:  2004-06       Impact factor: 2.493

View more
  3 in total

1.  Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism.

Authors:  Ang Li; Yafeng Ma; Meng Jin; Susan Mason; Richard L Mort; Karen Blyth; Lionel Larue; Owen J Sansom; Laura M Machesky
Journal:  J Invest Dermatol       Date:  2012-06-21       Impact factor: 8.551

Review 2.  Simulants of Malignant Melanoma.

Authors:  Gérald E Piérard; Claudine Piérard-Franchimont; Philippe Delvenne
Journal:  Oncol Rev       Date:  2015-08-05

Review 3.  Conventional and Atypical Deep Penetrating Nevus, Deep Penetrating Nevus-like Melanoma, and Related Variants.

Authors:  Pavandeep Gill; Phyu P Aung
Journal:  Biology (Basel)       Date:  2022-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.